Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies.
Ocera
Ocera Therapeutics is now a part of MallinckrodtTo learn more about our development product OCR-002 (l-ornithine phenylacetate), visit our pipeline page.
|
 |
Our Culture
From philanthropic efforts to advocacy initiatives, we are living our values throughout our communities.
Learn How